Link to this page
Clinical Trials Ontology - Neurodegenerative Diseases
Last uploaded:
May 26, 2020
Jump to:
| Preferred Name | Biomarkers in neurology | |
| Synonyms |
|
|
| ID |
http://www.semanticweb.org/ontologies/2012/0/Ontology1325521724189.owl#Biomarkers_in_Neurology |
|
| isDefinedBy |
A biomarkers Definitions Working Group that included members from the FDA, NIH, universities and industries recently refined definitions for surrogate outcomes, biomarkers, pharmacodynamic markers and clinical endpoints. A biological marker (Biomarker) can be defined as a characteristics that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic process or pharmacologic responses to a therapeutic intervention.
|
|
| label |
Biomarkers in neurology
|
|
| prefixIRI |
Ontology1325521724189:Biomarkers_in_Neurology
|
|
| prefLabel |
Biomarkers in neurology
|
|
| Reference |
Gisele silva, Karen Furie. " Biomarkers in Neurology". Front Neurol Neurosci. Basel,karger,2009,vol 25, pp 55-61
|
|
| Synonyms |
Biomarkers in Neurodegenerative Diseases
|
|
| subClassOf |
http://www.semanticweb.org/ontologies/2012/0/Ontology1325521724189.owl#Pilot_Trials |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |